Page last updated: 2024-10-31

metoclopramide and Dermatomyositis, Adult Type

metoclopramide has been researched along with Dermatomyositis, Adult Type in 1 studies

Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.

Research Excerpts

ExcerptRelevanceReference
"Two different types of drug eruptions were observed: five patients had development of a macular and partly papular or urticarial rash and angioedema and two patients had a generalized fixed drug eruption, primarily and predominantly at the sites of previous skin lesions of their underlying condition."5.28Drug eruptions from mesna. After cyclophosphamide treatment of patients with systemic lupus erythematosus and dermatomyositis. ( Aberer, W; Tappeiner, G; Zonzits, E, 1992)
"Two different types of drug eruptions were observed: five patients had development of a macular and partly papular or urticarial rash and angioedema and two patients had a generalized fixed drug eruption, primarily and predominantly at the sites of previous skin lesions of their underlying condition."1.28Drug eruptions from mesna. After cyclophosphamide treatment of patients with systemic lupus erythematosus and dermatomyositis. ( Aberer, W; Tappeiner, G; Zonzits, E, 1992)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zonzits, E1
Aberer, W1
Tappeiner, G1

Other Studies

1 other study available for metoclopramide and Dermatomyositis, Adult Type

ArticleYear
Drug eruptions from mesna. After cyclophosphamide treatment of patients with systemic lupus erythematosus and dermatomyositis.
    Archives of dermatology, 1992, Volume: 128, Issue:1

    Topics: Adult; Biopsy; Cyclophosphamide; Dermatomyositis; Drug Eruptions; Drug Therapy, Combination; Female;

1992